angiogenesis

June 7, 2017

Nintedanib-Chemo Combo Increases Mesothelioma Patients’ Disease-Progression-Free Period

News

Adding nintedanib to chemotherapy led to a 64 percent increase in the time it took for mesothelioma patients’ disease to progress, compared with chemo alone, according to updated results of ... Read more

January 25, 2017

Therapy Restricting Growth of Blood Vessels Failed in Mesothelioma Clinical Trial

News

An investigational cancer drug that restricts the growth of new blood vessels failed to improve disease in a Phase 2 clinical trial in patients with malignant pleural mesothelioma who progressed after ... Read more

September 7, 2016September 7, 2016

New Combination Therapy Seen to Suppress Tumor Growth in Malignant Mesothelioma

News

Researchers in Shanghai, China, have found a new combination therapy to be effective against tumor cell lines of malignant mesothelioma and non-small cell lung cancer (NSCLC), and suggest the therapy may become a new treatment regimen ... Read more